Brown E M, McGriff J T, Malinowski R W
Department of Anesthesiology, Wayne State University School of Medicine, Detroit, MI.
Can J Anaesth. 1989 May;36(3 Pt 1):307-10. doi: 10.1007/BF03010770.
Our experience with intravenous regional anaesthesia (IVRA) in 1,906 patients over a period of 20 years has confirmed that this technique is safe and effective. IVRA may be used to provide anaesthesia for surgery involving both the upper and lower extremities. The need for supplemental medication is ordinarily minimal, so the technique is particularly suitable for short procedures in an ambulatory surgery centre. Yet, prolonged surgery may be performed using a "continuous technique." Although various local anaesthetic agents may be used to induce IVRA no drug has been demonstrated to be superior to lidocaine. The major cause of failure of the technique or serious adverse effects is technical error. A specific protocol for avoiding technical error is presented. Significantly, over a period of 20 years, there has not been any mortality or major morbidity. The incidence of adverse reactions was 1.6 per cent and consisted of minor events such as transient dizziness, tinnitus or mild bradycardia.
我们在20年时间里对1906例患者进行静脉区域麻醉(IVRA)的经验证实,该技术安全有效。IVRA可用于为涉及上肢和下肢的手术提供麻醉。通常极少需要补充用药,因此该技术特别适用于门诊手术中心的短时间手术。然而,长时间手术可采用“连续技术”进行。虽然可使用各种局部麻醉剂诱导IVRA,但尚无药物被证明优于利多卡因。该技术失败或出现严重不良反应的主要原因是技术失误。本文介绍了避免技术失误的具体方案。重要的是,在20年期间,未发生任何死亡或严重并发症。不良反应发生率为1.6%,包括短暂头晕、耳鸣或轻度心动过缓等轻微事件。